ASO Author Reflections: A Novel Mechanism of Anticancer Effect of Skeletal Muscle-Derived Irisin in Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

ASO Author Reflections: A Novel Mechanism of Anticancer Effect of Skeletal Muscle-Derived Irisin in Pancreatic Ductal Adenocarcinoma

Published:2024-05-09 Issue:8 Volume:31 Page:5000-5001
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Sugimoto Tomoki,Iwagami Yoshifumi,Kobayashi Shogo,Yamanaka Chihiro,Sasaki Kazuki,Yamada Daisaku,Tomimaru Yoshito,Asaoka Tadafumi,Noda Takehiro,Takahashi Hidenori,Shimizu Junzo,Doki Yuichiro,Eguchi Hidetoshi

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-15349-y.pdf

Reference5 articles.

1. Yoon SJ, Shin SH, Yoon SK, et al. Appraisal of 5-year recurrence-free survival after surgery in pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2021;28(3):287–96. https://doi.org/10.1002/jhbp.815.(1).

2. Sugimoto M, Farnell MB, Nagorney DM, et al. Decreased skeletal muscle volume is a predictive factor for poorer survival in patients undergoing surgical resection for pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2018;22(5):831–9. https://doi.org/10.1007/s11605-018-3695-z.

3. Pedersen BK, Steensberg A, Fischer C, et al. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil. 2003;24(2–3):113–9. https://doi.org/10.1023/a:1026070911202.

4. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–8. https://doi.org/10.1038/nature10777.

5. Sugimoto T, Iwagami Y, Kobayashi S, et al. Skeletal muscle-derived irisin enhances gemcitabine sensitivity and suppresses migration ability in pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15118-x.